To determine whether Galectin-1 mediates sorafenib sensitivity and ferroptosis activation in HCC cells, we conducted a loss-of-function experiment to verify whether Galectin-1 mediates sorafenib resistance in HCC cells. Here, LGALS1 is linked to hepatocellular carcinoma.